ENRICO TIRRI
The lecture has not been included in the educational program CME From patient side: the role of Ixekizumab in patient reported outcomes
March, 31 | 17:05 - 17:25 , Aula Partenope Federico II
The lecture has not been included in the educational program CME The recognition and management of early PsA: which role for the IL23 inhibitor GuselKumab?
March, 31 | 17:25 - 17:45 , Aula Partenope Federico II